Status:
UNKNOWN
Esophagogastroduodenoscopy (EGD) is an Aerosol-generating Procedure: Proof of Concept Study
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Aerosol-generating Procedure, Esophagogastroduodenoscopy
Eligibility:
All Genders
Brief Summary
The disease COVID-19 has been classified as pandemic by World Health Organisation (WHO) in March 2020. This poses a risk to healthcare workers. Whether esophagogastroduodenoscopy (EGD) is a aerosol-ge...
Detailed Description
The disease COVID-19 has been classified as pandemic by World Health Organisation (WHO) in March 2020. This poses a risk to healthcare workers. Whether esophagogastroduodenoscopy (EGD) is a aerosol-ge...
Eligibility Criteria
Inclusion
- All patients undergoing EGD in the endoscopy unit of Prince of wales Hospital, Shatin, Hong Kong
Exclusion
- EGD cannot be completed due to patient's condition
- Patients who are unstable and require extra medical attention
- Patients who refuse
- Patients who are not fit for consent
Key Trial Info
Start Date :
May 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04400734
Start Date
May 7 2020
End Date
January 31 2021
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of hong Kong
Hong Kong, Hong Kong